Clinical Trials Sponsored by Agen Biomedical
Total 3781 results
-
AmgenCompletedSarcoma | Soft Tissue Sarcoma | Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma
-
AmgenCompleted
-
AmgenTerminated
-
AmgenCompletedSystemic Lupus ErythematosusUnited States, United Kingdom
-
AmgenCompletedCrohn's Disease | Ulcerative ColitisUnited States, Australia
-
AmgenCompletedCastrate-resistant Prostate CancerUnited Kingdom, Czech Republic
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedMigraineUnited States
-
AmgenCompleted
-
AmgenCompletedSecondary HyperparathyroidismUnited States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
-
AmgenCompletedDiabetes MellitusUnited States, Puerto Rico, Poland, Estonia, Czech Republic
-
AmgenCompletedLymphoma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large Cell Lymphoma | Low Grade Lymphoma
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple MyelomaUnited Kingdom, Czech Republic
-
AmgenCompletedChronic Kidney DiseaseUnited States, Puerto Rico
-
AmgenTerminatedCutaneous Lupus | LupusUnited States, Australia, Canada
-
AmgenCompletedDetermination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)Myelodysplastic Syndromes | Thrombocytopenia | MDS | Refractory Cytopenias
-
AmgenCompletedGastric Cancer | Esophageal Cancer | Esophagogastric Junction Adenocarcinoma
-
AmgenCompletedThrombocytopenia | Idiopathic Thrombocytopenic Purpura | Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Thrombocytopenic Purpura
-
AmgenWithdrawn
-
AmgenTerminated
-
AmgenCompletedOsteoporosis | Osteopenia | Low Bone Mineral Density
-
AmgenCompleted
-
AmgenCompleted
-
AmgenCompletedChronic Kidney Disease | Kidney Disease
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism
-
AmgenCompleted
-
AmgenCompletedEnd Stage Renal Disease | Secondary Hyperparathyroidism
-
AmgenCompletedAnemia | Non-Myeloid Malignancies
-
AmgenCompletedPsoriasisNew Zealand, Australia
-
AmgenTerminatedSchizophreniaUnited States
-
AmgenCompletedAdvanced Solid Tumors
-
AmgenCompletedCancer | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Thrombocytopenia | Oncology | Chemotherapy-Induced Thrombocytopenia
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma
-
AmgenCompleted
-
AmgenCompletedHealthy Volunteers
-
AmgenCompleted
-
AmgenCompletedNeoplasm Metastasis | Lung Cancer | Non-small Cell Lung Cancer
-
AmgenCompletedBreast Cancer | Non-Hodgkin's Lymphoma | Ovarian Cancer | Lung Cancer | Neutropenia
-
AmgenCompletedSarcoma | Neutropenia
-
AmgenCompleted